Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
73,402,366
-
Share change
-
-2,499,905
-
Total reported value
-
$22,037,080,841
-
Put/Call ratio
-
141%
-
Price per share
-
$300.28
-
Number of holders
-
448
-
Value change
-
-$740,153,368
-
Number of buys
-
242
-
Number of sells
-
196
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2014
As of 31 Mar 2014,
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) was held by
448 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,402,366 shares.
The largest 10 holders included
Capital World Investors, FMR LLC, WELLINGTON MANAGEMENT CO LLP, PRICE T ROWE ASSOCIATES INC /MD/, SANDS CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, State Street Corp, Artisan Partners Limited Partnership, BlackRock Institutional Trust Company, N.A., and WELLS FARGO & COMPANY/MN.
This page lists
448
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.